These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 16131313)

  • 1. Evidence for host-driven selection of the HIV type 1 vpr gene in vivo during HIV disease progression in a transfusion-acquired cohort.
    Cali L; Wang B; Mikhail M; Gill MJ; Beckthold B; Salemi M; Jans DA; Piller SC; Saksena NK
    AIDS Res Hum Retroviruses; 2005 Aug; 21(8):728-33. PubMed ID: 16131313
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene defects clustered at the C-terminus of the vpr gene of HIV-1 in long-term nonprogressing mother and child pair: in vivo evolution of vpr quasispecies in blood and plasma.
    Wang B; Ge YC; Palasanthiran P; Xiang SH; Ziegler J; Dwyer DE; Randle C; Dowton D; Cunningham A; Saksena NK
    Virology; 1996 Sep; 223(1):224-32. PubMed ID: 8806556
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Full-length HIV type 1 genome analysis showing evidence for HIV type 1 transmission from a nonprogressor to two recipients who progressed to AIDS.
    Mikhail M; Wang B; Lemey P; Beckholdt B; Vandamme AM; Gill MJ; Saksena NK
    AIDS Res Hum Retroviruses; 2005 Jun; 21(6):575-9. PubMed ID: 15989463
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of viral evolutionary rate in HIV-1 disease progression in a linked cohort.
    Mikhail M; Wang B; Lemey P; Beckthold B; Vandamme AM; Gill MJ; Saksena NK
    Retrovirology; 2005 Jun; 2():41. PubMed ID: 15985187
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An HIV-1 infected long-term non-progressor (LTNP): molecular analysis of HIV-1 strains in the vpr and nef genes.
    Saksena NK; Ge YC; Wang B; Xiang SH; Dwyer DE; Randle C; Palasanthiran P; Ziegler J; Cunningham AL
    Ann Acad Med Singap; 1996 Nov; 25(6):848-54. PubMed ID: 9055015
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular characterization of the HIV type 1 vpr gene in infected Chinese former blood/plasma donors at different stages of diseases.
    Shen C; Gupta P; Wu H; Chen X; Huang X; Zhou Y; Chen Y
    AIDS Res Hum Retroviruses; 2008 Apr; 24(4):661-6. PubMed ID: 18366311
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vpr and HIV-1 disease progression: R77Q mutation is associated with long-term control of HIV-1 infection in different groups of patients.
    Mologni D; Citterio P; Menzaghi B; Zanone Poma B; Riva C; Broggini V; Sinicco A; Milazzo L; Adorni F; Rusconi S; Galli M; Riva A;
    AIDS; 2006 Feb; 20(4):567-74. PubMed ID: 16470121
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic characterization of vif, vpr, and vpu sequences from long-term survivors of human immunodeficiency virus type 1 infection.
    Zhang L; Huang Y; Yuan H; Tuttleton S; Ho DD
    Virology; 1997 Feb; 228(2):340-9. PubMed ID: 9123841
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low conservation of functional domains of HIV type 1 vif and vpr genes in infected mothers correlates with lack of vertical transmission.
    Yedavalli VR; Ahmad N
    AIDS Res Hum Retroviruses; 2001 Jul; 17(10):911-23. PubMed ID: 11461677
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional relevance of nonsynonymous mutations in the HIV-1 tat gene within an epidemiologically-linked transmission cohort.
    Sivakumaran H; Wang B; Gill MJ; Beckholdt B; Saksena NK; Harrich D
    Virol J; 2007 Oct; 4():107. PubMed ID: 17958917
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Virion-targeted viral inactivation: new therapy against viral infection.
    Okui N; Kitamura Y; Kobayashi N; Sakuma R; Ishikawa T; Kitamura T
    Mol Urol; 2001; 5(2):59-66. PubMed ID: 11690549
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic characterization of HIV before widespread testing of HIV vaccine candidates at a clinical trial site in Pretoria, South Africa.
    Musyoki A; Mothapo K; Rakgole J; Lukhwareni A; Bessong P; Selabe G; Bredell H; Williamson C; Mphahlele MJ
    AIDS Res Hum Retroviruses; 2012 Sep; 28(9):1131-8. PubMed ID: 22106990
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HIV-1 Vpr: genetic diversity and functional features from the perspective of structure.
    Tungaturthi PK; Sawaya BE; Ayyavoo V; Murali R; Srinivasan A
    DNA Cell Biol; 2004 Apr; 23(4):207-22. PubMed ID: 15142378
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Specific amino acids in HIV-1 Vpr are significantly associated with differences in patient neurocognitive status.
    Dampier W; Antell GC; Aiamkitsumrit B; Nonnemacher MR; Jacobson JM; Pirrone V; Zhong W; Kercher K; Passic S; Williams JW; James T; Devlin KN; Giovannetti T; Libon DJ; Szep Z; Ehrlich GD; Wigdahl B; Krebs FC
    J Neurovirol; 2017 Feb; 23(1):113-124. PubMed ID: 27400931
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gross defects in the vpr and vpu genes of HIV type 1 cannot explain the differences in RNA copy number between long-term asymptomatics and progressors.
    Cornelissen M; Kuiken C; Zorgdrager F; Hartman S; Goudsmit J
    AIDS Res Hum Retroviruses; 1997 Feb; 13(3):247-52. PubMed ID: 9115812
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nonsense mutations in the vpr gene of HIV-1 during in vitro virus passage and in HIV-1 carrier-derived peripheral blood mononuclear cells.
    Nakaya T; Fujinaga K; Kishi M; Oka S; Kurata T; Jones IM; Ikuta K
    FEBS Lett; 1994 Oct; 354(1):17-22. PubMed ID: 7957894
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of gag and pol sequences from long-term survivors of human immunodeficiency virus type 1 infection.
    Huang Y; Zhang L; Ho DD
    Virology; 1998 Jan; 240(1):36-49. PubMed ID: 9448687
    [TBL] [Abstract][Full Text] [Related]  

  • 18. nef/long terminal repeat quasispecies from HIV type 1-infected Mexican patients with different progression patterns and their pathogenesis in hu-PBL-SCID mice.
    Gómez-Román VR; Vázquez JA; del Carmen Basualdo M; Estrada FJ; Ramos-Kuri M; Soler C
    AIDS Res Hum Retroviruses; 2000 Mar; 16(5):441-52. PubMed ID: 10772530
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The majority of currently circulating human immunodeficiency virus type 1 clade B viruses fail to prime cytotoxic T-lymphocyte responses against an otherwise immunodominant HLA-A2-restricted epitope: implications for vaccine design.
    Altfeld M; Allen TM; Kalife ET; Frahm N; Addo MM; Mothe BR; Rathod A; Reyor LL; Harlow J; Yu XG; Perkins B; Robinson LK; Sidney J; Alter G; Lichterfeld M; Sette A; Rosenberg ES; Goulder PJ; Brander C; Walker BD
    J Virol; 2005 Apr; 79(8):5000-5. PubMed ID: 15795285
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic Analysis of HIV-1
    Love M; Samora L; Barker D; Zukosky P; Kummet N; Ahmad A; Bernhardt D; Tripathi M; Klotz S; Ahmad N
    Curr HIV Res; 2022; 20(4):309-320. PubMed ID: 35792120
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.